IN2014MN01384A - - Google Patents

Info

Publication number
IN2014MN01384A
IN2014MN01384A IN1384MUN2014A IN2014MN01384A IN 2014MN01384 A IN2014MN01384 A IN 2014MN01384A IN 1384MUN2014 A IN1384MUN2014 A IN 1384MUN2014A IN 2014MN01384 A IN2014MN01384 A IN 2014MN01384A
Authority
IN
India
Prior art keywords
amino acids
hiv
fusion
inhibitor
pharmaceutical composition
Prior art date
Application number
Inventor
Bruce Albert Malcolm
Johannes Wilhelmus J Thuring
Christophe Francis Robert Nestor Buyck
Wim Bert Griet Schepens
Maria Aldegonda Jacoba Kriek
Wilhelmus Martinus Maria Schaaper
Jelle Wouter Slootstra
Peter Timmerman
Original Assignee
Janssen R & D Ireland
Pepscan Systems Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen R & D Ireland, Pepscan Systems Bv filed Critical Janssen R & D Ireland
Publication of IN2014MN01384A publication Critical patent/IN2014MN01384A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16033—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention concerns an inhibitor of Human Immunodeficiency Virus (HIV) fusion with or HIV entry in a host cell comprising at least 24 but preferably 26 contiguous amino acids; the invention also relates to a pharmaceutical composition comprising said amino acids.
IN1384MUN2014 2011-12-19 2012-12-18 IN2014MN01384A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11194340 2011-12-19
PCT/EP2012/075956 WO2013092591A1 (en) 2011-12-19 2012-12-18 Hiv membrane fusion inhibitors

Publications (1)

Publication Number Publication Date
IN2014MN01384A true IN2014MN01384A (en) 2015-04-03

Family

ID=47501221

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1384MUN2014 IN2014MN01384A (en) 2011-12-19 2012-12-18

Country Status (8)

Country Link
US (1) US20140357577A1 (en)
EP (1) EP2794636A1 (en)
JP (1) JP2015502378A (en)
CN (1) CN104159914A (en)
BR (1) BR112014014917A2 (en)
IN (1) IN2014MN01384A (en)
RU (1) RU2014129907A (en)
WO (1) WO2013092591A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9670250B2 (en) * 2012-04-27 2017-06-06 The Trustees Of The University Of Pennsylvania Alpha-helical peptidomimetic inhibitors and methods using same
CN109320593A (en) * 2018-11-05 2019-02-12 中国人民解放军军事科学院军事医学研究院 Helical polypeptide for inhibiting HIV infection and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339069B1 (en) * 1996-10-15 2002-01-15 Elan Pharmaceuticalstechnologies, Inc. Peptide-lipid conjugates, liposomes and lipsomal drug delivery
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
US20080025977A1 (en) * 2003-04-14 2008-01-31 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of CD59
WO2005067960A1 (en) * 2004-01-07 2005-07-28 Trimeris, Inc. HIV gp41 HR2-DERIVED SYNTHETIC PEPTIDES, AND THEIR USE IN THERAPY TO INHIBIT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS
JP5372380B2 (en) * 2005-01-24 2013-12-18 ペプスキャン システムズ ベー．フェー． Binding compounds, immunogenic compounds and peptidomimetics
WO2007097903A2 (en) * 2006-02-02 2007-08-30 Trimeris, Inc. Hiv fusion inhibitor peptides with improved biological properties
US20080131428A1 (en) * 2006-02-24 2008-06-05 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of TROP-2
EP1996215A2 (en) * 2006-02-28 2008-12-03 Trustees Of Boston University Metabolic regulators and uses thereof
CA2638868A1 (en) * 2006-02-28 2007-11-22 Eli Lilly And Company Selective vpac2 receptor peptide agonists
GB0720503D0 (en) * 2007-10-22 2007-11-28 Angeletti P Ist Richerche Bio New compound

Also Published As

Publication number Publication date
WO2013092591A1 (en) 2013-06-27
JP2015502378A (en) 2015-01-22
RU2014129907A (en) 2016-02-10
CN104159914A (en) 2014-11-19
BR112014014917A2 (en) 2018-05-15
US20140357577A1 (en) 2014-12-04
EP2794636A1 (en) 2014-10-29

Similar Documents

Publication Publication Date Title
CY1125155T1 (en) CRYSTAL FORMS OF PROLYL HYDROSYLASE INHIBITOR
ES2666720T3 (en) Composition to prevent or treat cervical cancer with an immunity enhancer against human papillomavirus
MX358224B (en) Pharmaceutical composition for treatment and/or prevention of liver cancer.
CO6811816A2 (en) Compositions containing, methods that involve, and uses of dolastatin derivatives linked to unnatural amino acids
MX342716B (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease.
BR112015013525A2 (en) a method for producing a fusion protein as well as a composition comprising a fusion protein
ECSP13012534A (en) PHARMACEUTICAL COMPOSITION
WO2011036564A3 (en) Hyperblebbing shigella strains
PH12015501156A1 (en) Pharmaceutical compositions
MX336715B (en) PURIFICATION OF IDURONATE-2-SULFATASE.
EP3363458A3 (en) A peptide
IL231421A (en) Lupane and its analogs substituted in position 3ß with carboxyalkylcarbonyloxy and in position 17 with (substituted alkyl)amino, as well as anti-hiv pharmaceutical compositions comprising them
CA2864145A1 (en) Autophagy-inducing peptide
DOP2012000050A (en) NEW COMPOSITIONS OF 1- [2- (2,4-DIMETIL-PHENYL SULFANIL) -PENYL] PIPERAZINA
IN2014CN00572A (en)
ZA201307529B (en) Truncated hiv envelope proteins (env), methods and compositions related thereto
PH12013500784A1 (en) Pharmaceutical compositions comprising nano size droplets of skin whitening agents
EA201390955A1 (en) ROBO1-FC fusion protein for use in the treatment of hepatocarcinoma
MX2015016410A (en) Esters of oligo-hydroxycarboxylic acids and use thereof.
MX2014014878A (en) Combination of therapeutic agents for treating hcv infection.
WO2012115903A3 (en) Yeast strain for the production of proteins with modified o-glycosylation
EP2678031A4 (en) GP96-IG-VIS / COMBINED HIV OF CELL ORIGIN, RECOMBINANT GP120 PROTEIN VACCINATION FOR SCREEN PROTECTION / HIV
UA103290C2 (en) Pharmaceutical composition of ibuprofen for injection
IN2014MN01384A (en)
MX375183B (en) ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME.